T/NBPIA 008-2021 Blood purification room quality control specifications
T/NBPIA 008-2021 Blood purification room quality control specifications
Basic Information
Scope
Main technical content: 1. Specify that the setup of blood purification rooms, services, dialysis solution, dialysis water, and infection control should comply with the requirements of T/NBPIA 001, T/CHAS 10-2-20, T/NBPIA 002, T/NBPIA 003, T/NBPIA 006.1, and T/NBPIA 006.2. 2. Define quality management objectives for clinical indicators such as blood pressure, volume overload, and dialysis access. 3. Specify quality management objectives for clinical laboratory indicators including hemoglobin, chronic kidney disease–mineral and bone disorder, serum potassium, dialysis adequacy, serum iron status, bicarbonate, and peritoneal equilibrium test. 4. Set quality management objectives for examination indicators such as electrocardiograms, echocardiograms, and bone densitometry. 5. Establish registration and management objectives for acute (cardiovascular events, hypoglycemia, hypertension, gastrointestinal bleeding, etc.) and chronic complications (tumors, tuberculosis, etc.). 6. Define quality management systems and procedures for blood purification rooms. 7. Specify how to conduct inspections of blood purification room quality management. 8. Appendices A–M provide forms for quality management processes, recording the compliance rates of monitored indicators during a specified period, common issues needing improvement in blood purification rooms, and personalized issues requiring improvement in patients. Improvement plans for the next quality control phase are also proposed. Since most quality management indicators are the same for patients receiving hemodialysis or peritoneal dialysis, this document does not separate the two. Peritoneal dialysis-specific quality management indicators can be found in the following corresponding sections: 4.5.1 Blood pressure management requirements; 4.5.3 Management requirements for dialysis access; 4.6.1 Hemoglobin testing management requirements; 4.6.3 Serum potassium testing management requirements; 4